ucsf logo

Nida F. Degesys, MD

She | Her | HersEmergency Medicine
Portrait of Nida F. Degesys
Portrait of Nida F. Degesys
ucsf logo

Nida F. Degesys, MD

She | Her | HersEmergency Medicine

On this page

About me

Dr. Nida F. Degesys is an emergency care doctor who specializes in the needs of older cognitively impaired adults when seen in the emergency department.

In research, Degesys' main focus is geriatric emergency medicine. Her research on the reuse and extended use of N95 masks has been published in the Journal of the American Medical Association (JAMA).

Degesys earned her medical degree from Northeast Ohio Medical University. She completed a residency in emergency medicine at UCSF and a fellowship in emergency medicine administration at Stanford University School of Medicine.

Degesys serves in several leadership roles at UCSF, including medical director of the Age-Friendly Emergency Department, assistant medical director of the emergency department at the Parnassus campus, and administrative fellowship director for emergency medicine. In 2023, she received an award for early career achievement from the Academy of Geriatric Emergency Medicine and the National Emergency Medicine Junior Faculty Teaching Award from the American College of Emergency Physicians.

Prior to starting her career in medicine, Degesys served in the Peace Corps in Panama.

Education & training

Board certification

  • Emergency Medicine, American Board of Emergency Medicine

Residency

  • Emergency Medicine, UCSF Graduate Medical Education

Internship

  • Emergency Medicine, UCSF Graduate Medical Education

Degree

  • MD, Northeastern Ohio Universities College of Medicine

My expertise

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.